SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Verso Corporation (VRS) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分: 33/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — VRS
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.72
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.09
每股账面价值$0.00
每股营收$37.33
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2012 |
$-3.29 |
$1.47B |
$-173.83M |
-11.8% |
| 2013 |
$-2.09 |
$1.39B |
$-111.21M |
-8% |
| 2014 |
$-6.62 |
$1.3B |
$-352.96M |
-27.2% |
| 2015 |
$-5.19 |
$3.12B |
$-422M |
-13.5% |
| 2016 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2017 |
$-0.87 |
$2.46B |
$-30M |
-1.2% |
| 2018 |
$4.87 |
$2.68B |
$171M |
6.4% |
| 2019 |
$2.73 |
$2.44B |
$96M |
3.9% |
| 2020 |
$-2.95 |
$1.36B |
$-101M |
-7.4% |
| 2021 |
$-0.09 |
$1.28B |
$-3M |
-0.2% |